EYE 6.06% 15.5¢ nova eye medical limited

Ann: Full Year Financial Results, page-108

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 11,012 Posts.
    lightbulb Created with Sketch. 1310
    Looks like you haven't been able to identify the difference between material improvement in an operating division and underlying profit in a business. Happy to explain it but I think it would be wasted here, so keep on pumping lol.

    Speaking of divisions, are the 'Analysts' E&P working in the same division of Evans & Partners which is the Lead Underwriter for the last EYE Nova CR? They shared in $400k costs (plus razzle dazzle) from the $8 mil which netted EYE $7.6 mil and I'd be taking a very strong bet that they will be there front and centre next time. Translated - I would treat their valuations with a grain of salt.

    Your new slide is as bad as the last one. Divisions, EBITDA, half year losses, surging toward profitability. BS, there are only 2 things that matter - profits and having enough money to keep rolling
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
15.5¢
Change
-0.010(6.06%)
Mkt cap ! $35.50M
Open High Low Value Volume
16.5¢ 16.5¢ 15.5¢ $58.82K 372.8K

Buyers (Bids)

No. Vol. Price($)
2 14029 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 83525 2
View Market Depth
Last trade - 15.44pm 04/11/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.